These results were further supported by the correlation between CTHRC1-induced Ang-2 expression in ECs and TEM infiltration into the tumor tissues, which was demonstrated by injection of a CTHRC1-neutralizing antibody into Pancreatic ductal adenocarcinoma models. The gene discussed is CTHRC1; the disease is pancreatic ductal adenocarcinoma.